DOBRINA, ALDO
DOBRINA, ALDO
Facoltà Dipartimentale di Medicina e Chirurgia
Endothelial dysfunction and activation as an expression of disease: role of prostacyclin analogs
2005-01-01 Zardi, Em; Zardi, Dm; Cacciapaglia, F; Dobrina, A; Amoroso, A; Picardi, A; Afeltra, A
Enhanced portal flow velocity and volume following Iloprost treatment
2003-01-01 Zardi, Em; Picardi, A; Ambrosino, G; Fazio, Vm; Dobrina, A; Afeltra, A; Frego, M.
Hepatic PPARs: their role in liver physiology, fibrosis and treatment
2013-01-01 Zardi, E M; Navarini, L; Sambataro, G; Piccinni, P; Sambataro, F M; Spina, C; Dobrina, A
Iloprost enhances portal flow velocity and volume in patients with systemic sclerosis
2006-01-01 Zardi, Em; Picardi, A; Ambrosino, G; Fazio, Vm; Dobrina, A; Frego, M; Afeltra, A; Lumachi, F
Iloprost: an adjunctive approach to chronic viral hepatitis treatment
2005-01-01 Zardi, Em; Vespasiani Gentilucci, U; Picardi, A; Ambrosino, G; Fazio, Vm; Dobrina, A; Afeltra, A
Improved hepatic perfusion after iloprost infusion in patients with HCV chronic infection: a pilot study with possible therapeutic implications
2004-01-01 Zardi, Em; Picardi, A; Fazio, Vm; Ambrosino, G; Dobrina, A; Zullo, M; Zennaro, D; Afeltra, A
Portal diameter in the diagnosis of esophageal varices in 266 cirrhotic patients: which role?
2007-01-01 Zardi, Em; Uwechie, V; Vespasiani Gentilucci, U; Dobrina, A; Petitti, T; Laghi, V; Picardi, A; Afeltra, A
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Endothelial dysfunction and activation as an expression of disease: role of prostacyclin analogs | 1-gen-2005 | Zardi, Em; Zardi, Dm; Cacciapaglia, F; Dobrina, A; Amoroso, A; Picardi, A; Afeltra, A | |
| Enhanced portal flow velocity and volume following Iloprost treatment | 1-gen-2003 | Zardi, Em; Picardi, A; Ambrosino, G; Fazio, Vm; Dobrina, A; Afeltra, A; Frego, M. | |
| Hepatic PPARs: their role in liver physiology, fibrosis and treatment | 1-gen-2013 | Zardi, E M; Navarini, L; Sambataro, G; Piccinni, P; Sambataro, F M; Spina, C; Dobrina, A | |
| Iloprost enhances portal flow velocity and volume in patients with systemic sclerosis | 1-gen-2006 | Zardi, Em; Picardi, A; Ambrosino, G; Fazio, Vm; Dobrina, A; Frego, M; Afeltra, A; Lumachi, F | |
| Iloprost: an adjunctive approach to chronic viral hepatitis treatment | 1-gen-2005 | Zardi, Em; Vespasiani Gentilucci, U; Picardi, A; Ambrosino, G; Fazio, Vm; Dobrina, A; Afeltra, A | |
| Improved hepatic perfusion after iloprost infusion in patients with HCV chronic infection: a pilot study with possible therapeutic implications | 1-gen-2004 | Zardi, Em; Picardi, A; Fazio, Vm; Ambrosino, G; Dobrina, A; Zullo, M; Zennaro, D; Afeltra, A | |
| Portal diameter in the diagnosis of esophageal varices in 266 cirrhotic patients: which role? | 1-gen-2007 | Zardi, Em; Uwechie, V; Vespasiani Gentilucci, U; Dobrina, A; Petitti, T; Laghi, V; Picardi, A; Afeltra, A |